Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
CDC Chronic Kidney Disease Surveillance Health Survey CDC NIDDK The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) assists the Centers for Disease Control and Prevention (CDC) in its surveillance program of chronic kidney disease.
CDC Integration with GrantSolutions Resource Development ACF, CDC OD/OER Collaboration with GrantSolutions to allow the Centers for Disease Control and Prevention (CDC) Research programs to seamlessly use electronic Research Administration (eRA) research grant support services, including the eRA Commons grantee portal and the eRA Peer Review suite while having grants management staff process awards within GrantSolutions.
CDC Office of Public Health Genomics Public Education Campaign CDC NHLBI This collaboration seeks to define and implement a translational trajectory for scientific discoveries in genomics and related fields to population health benefits in health areas relevant to National Heart, Lung, and Blood Institute (NHLBI) including, heart, lung, blood, and sleep disorders.
CDC-NIH Lyme Disease Serum Sample Repository Resource Development CDC, OS NIAID Initiated in 2008, this resource was made available to the scientific community on a broad basis in late 2011. Lyme disease and related serum samples are available upon request for testing and comparison of new and current diagnostic tests with a common serum sample set for standardization. Samples are distributed by the Centers for Disease Control and Prevention (CDC). CDC and National Institutes of Health (NIH) both provided support to acquire the samples and continue to work together to ensure the scientific community has access to samples needed for Lyme disease diagnostic test development.
CDC/RAND Technical Expert Panel on Behavioral Health Surveillance in Disasters Committee, Work group, Advisory group, or Task Force CDC NIMH The Centers for Disease Control and Prevention has contracted with the RAND Corporation to develop guidance for public health and mental health departments on how to use existing data and resources to strengthen behavioral health monitoring and surveillance during public health emergencies. The three research questions guiding this work are: 1) what strategies are currently in use at state, tribal, local, and territorial levels to monitor behavioral health during public health emergencies? 2) what data sources, indicators, and methodologic approaches could public health and mental health departments use to strengthen behavioral health surveillance during public health emergencies? 3) what are recommendations for the interpretation and use of behavioral health surveillance information during public health emergencies?
Cervical screening guidelines Resource Development CDC, HRSA, FDA NCI The National Cancer Institute (NCI) is generating risk estimates that inform cervical screening and management guidelines. NCI is working with CDC, HRSA, and FDA to collect study populations, conduct risk estimation, and disseminate guidelines.
Characterize Emerging HIV Strains from Blood Donors and Patients Resource Development FDA NIAID This initiative will characterize emerging HIV strains from blood donors and patients to determine viral tropism based on co-receptor usage strains. It will update the global viral panels to analyze multiple, diverse isolates from different parts of the world. This activity is part of the National Institute of Allergy and Infectious Diseases (NIAID) ongoing efforts to develop a well-characterized repository for diagnostics, and drug and vaccine studies.
CHEMM (Chemical Hazards Emergency Medical Management) Resource Development ATSDR, CDC, IOS NLM, NICHD This activity is to develop and maintain a comprehensive web resource and mobile app (in conjunction with the Wireless Information System for Emergency Responders [WISER]). Chemical Hazards Emergency Medical Management (CHEMM) is a tool designed to provide access to comprehensive sets of information about chemical hazards and emergency medical management via a user-friendly interface.
Cherokee Cancer Registry (CNCR) Resource Development IHS NCI The Cherokee Nation Cancer Registry (CNCR) was established in 1997. Since its creation the registry has successfully conducted population-based cancer surveillance for the Cherokee Nation services population living within the 14 county Tribal Jurisdictional service area, in accordance with prevailing standards required by the Surveillance, Epidemiology, and End Results (SEER) Program. All data is abstracted and coded according to SEER standards. We submit data to SEER twice a year, through the New Mexico Tumor Registry in the prescribed format.
Childhood Cancer Data Initiative (CCDI), National Childhood Cancer Registry (NCCR) Resource Development CDC NCI The NCCR has been established by relying on a core of registry data from 1995 forward for all cancers diagnosed in children aged 0-19. NCI SEER and CDC NPCR registries are submitting population-based registry data and this is linked with a variety of other data sources (e.g., claims, molecular characterization, pharmacy, Virtual Pooled Registry, research studies, SDoH, Cancer Center supplements) to obtain a longitudinal understanding of treatment, procedures, risk factors, and outcomes.